ConductScience.org, home

Paper41744896

Elevated Risk of Endometrial Cancer and Precursor Lesions in Patients With Myotonic Dystrophy: A Retrospective Study at a Single Institution in Japan.

Hano R and 9 others. J Obstet Gynaecol Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Elevated Risk of Endometrial Cancer and Precursor Lesions in Patients With Myotonic Dystrophy: A Retrospective Study at a Single Institution in Japan. Papers, record 41744896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41744896

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elevated Risk of Endometrial Cancer and Precursor Lesions in Patients With Myotonic Dystrophy: A Retrospective Study at a Single Institution in Japan.
PubMed
Journal
J Obstet Gynaecol Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hano RRuka
2Ando HHirofumi
3Fujioka MMarina
4Nakajima MMasako
5Shinagawa MManaka
6Takeuchi HHodaka
7Shinagawa MMitsuko
8Kobara HHisanorihttps://orcid.org/0000-0002-9786-4651
9Yoshinaga TTsuneaki
10Miyamoto TTsutomu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11184720Hypothalamic-pituitary-gonadal function in patients with myotonic dystrophy.J Clin Endocrinol Metab1975https://conductscience.org/library/papers/1184720PubMed
234555870Rate of premalignant and malignant endometrial lesion in "low-risk" premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy.Obstet Gynecol Sci2021https://conductscience.org/library/papers/34555870PubMed
319642006Hypothesis: neoplasms in myotonic dystrophy.Cancer Causes Control2009https://conductscience.org/library/papers/19642006PubMed
435483324Global Prevalence of Myotonic Dystrophy: An Updated Systematic Review and Meta-Analysis.Neuroepidemiology2022https://conductscience.org/library/papers/35483324PubMed
531583190Consensus-based care recommendations for adults with myotonic dystrophy type 2.Neurol Clin Pract2019https://conductscience.org/library/papers/31583190PubMed
628662292Benign and malignant tumors in the UK myotonic dystrophy patient registry.Muscle Nerve2018https://conductscience.org/library/papers/28662292PubMed
723208313Investigation of the freely available easy-to-use software 'EZR' for medical statistics.Bone Marrow Transplant2013https://conductscience.org/library/papers/23208313PubMed
81486700Fertility in myotonic dystrophy in Saguenay-Lac-St-Jean: a historical perspective.Clin Genet1992https://conductscience.org/library/papers/1486700PubMed
927558368Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.Neurology2016https://conductscience.org/library/papers/27558368PubMed
1031402615Benign tumors in myotonic dystrophy type I target disease-related cancer sites.Ann Clin Transl Neurol2019https://conductscience.org/library/papers/31402615PubMed
1140802186Spectrum of Cancers and Their Prognosis Among Patients With Myotonic Dystrophy.JAMA Netw Open2025https://conductscience.org/library/papers/40802186PubMed
1218597886RNA-binding proteins in human genetic disease.Trends Genet2008https://conductscience.org/library/papers/18597886PubMed
1333172626Cancer frequency among the patients with myotonic dystrophy in the South Korean population using the national health insurance database.J Neurol Sci2021https://conductscience.org/library/papers/33172626PubMed
1430588381Consensus-based care recommendations for adults with myotonic dystrophy type 1.Neurol Clin Pract2018https://conductscience.org/library/papers/30588381PubMed
1527064430A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.Muscle Nerve2016https://conductscience.org/library/papers/27064430PubMed
1622995693The myotonic dystrophies: molecular, clinical, and therapeutic challenges.Lancet Neurol2012https://conductscience.org/library/papers/22995693PubMed
1733305167Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center.Acta Myol2020https://conductscience.org/library/papers/33305167PubMed
1822166607Cancer risk among patients with myotonic muscular dystrophy.JAMA2011https://conductscience.org/library/papers/22166607PubMed
1939298705Cancer Risk in Patients With Muscular Dystrophy and Myotonic Dystrophy: A Register-Based Cohort Study.Neurology2024https://conductscience.org/library/papers/39298705PubMed
2026849574Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.PLoS One2016https://conductscience.org/library/papers/26849574PubMed

See all 25 referencesDownload CSV of references

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41744896

GET https://conductscience.org/api/papers/v1/41744896/references?page=2